SI2247558T1 - Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij - Google Patents

Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij

Info

Publication number
SI2247558T1
SI2247558T1 SI200932157T SI200932157T SI2247558T1 SI 2247558 T1 SI2247558 T1 SI 2247558T1 SI 200932157 T SI200932157 T SI 200932157T SI 200932157 T SI200932157 T SI 200932157T SI 2247558 T1 SI2247558 T1 SI 2247558T1
Authority
SI
Slovenia
Prior art keywords
imaging agents
neurological dysfunction
novel imaging
detecting neurological
detecting
Prior art date
Application number
SI200932157T
Other languages
English (en)
Inventor
Hartmuth C. Kolb
Joseph C. Walsh
Qianwa Liang
Brian A. Duclos
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40627498&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2247558(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of SI2247558T1 publication Critical patent/SI2247558T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
SI200932157T 2008-02-14 2009-02-17 Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij SI2247558T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6610108P 2008-02-14 2008-02-14
PCT/US2009/000961 WO2009102498A1 (en) 2008-02-14 2009-02-17 Novel imaging agents for detecting neurological dysfunction
EP09711194.2A EP2247558B1 (en) 2008-02-14 2009-02-17 Novel imaging agents for detecting neurological dysfunction

Publications (1)

Publication Number Publication Date
SI2247558T1 true SI2247558T1 (sl) 2022-07-29

Family

ID=40627498

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200932157T SI2247558T1 (sl) 2008-02-14 2009-02-17 Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij

Country Status (14)

Country Link
US (2) US20110046378A1 (sl)
EP (2) EP2599763A1 (sl)
JP (1) JP2011512354A (sl)
KR (1) KR20100135235A (sl)
CA (1) CA2715390A1 (sl)
DK (1) DK2247558T3 (sl)
ES (1) ES2907992T3 (sl)
HR (1) HRP20220401T3 (sl)
HU (1) HUE058352T2 (sl)
LT (1) LT2247558T (sl)
PL (1) PL2247558T3 (sl)
PT (1) PT2247558T (sl)
SI (1) SI2247558T1 (sl)
WO (1) WO2009102498A1 (sl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2247558T3 (pl) 2008-02-14 2022-05-02 Eli Lilly And Company Nowe środki obrazujące do wykrywania czynnościowych zaburzeń neurologicznych
US8932557B2 (en) * 2008-02-14 2015-01-13 Eli Lilly And Company Imaging agents for detecting neurological dysfunction
MX2011001070A (es) * 2008-08-08 2011-03-25 Neurosearch As Nuevos derivados de difenil 1,2,3-triazol utiles como moduladores de los receptores de acetilcolina nicotinicos.
JP5771525B2 (ja) * 2008-09-18 2015-09-02 セダーズ−シナイ メディカル センター アルツハイマー病を検出するための光学的方法
US8691187B2 (en) * 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
GB201016038D0 (en) 2010-09-24 2010-11-10 Ge Healthcare Ltd In vivo imaging method
DK2634177T3 (en) * 2010-10-29 2016-08-15 Clino Ltd TAU IMAGE SOUND
US20140275156A1 (en) * 2011-08-11 2014-09-18 Neuprotect Pty Ltd Flavonoid compounds, and methods of use thereof
US20130315825A1 (en) * 2012-05-03 2013-11-28 Washington University Tricyclic heteroaromatic compounds as alpha-synuclein ligands
EP2852572B1 (en) * 2012-05-22 2020-04-01 Eli Lilly and Company Carboline and carbazole based imaging agents for detecting neurological dysfunction
CA2894994C (en) 2012-12-21 2019-11-12 National Institute Of Radiological Sciences Compounds for imaging tau proteins that accumulate in brain
US20160115162A1 (en) 2013-05-31 2016-04-28 The General Hospital Corporation Radiosynthesis of Tau Radiopharmaceuticals
AR096721A1 (es) 2013-06-25 2016-01-27 Bristol Myers Squibb Co Compuestos de tetrahidrocarbazol y carbazol carboxamida sustituidos
SG11201510028PA (en) 2013-06-25 2016-01-28 Bristol Myers Squibb Co Carbazole carboxamide compounds useful as kinase inhibitors
PE20160159A1 (es) * 2013-10-08 2016-03-18 Hoffmann La Roche Derivados de diazacarbazol como ligandos de tau para pet
TWI667233B (zh) 2013-12-19 2019-08-01 德商拜耳製藥公司 新穎吲唑羧醯胺，其製備方法、含彼等之醫藥製劑及其製造醫藥之用途
US10662193B2 (en) 2014-01-21 2020-05-26 Ac Immune Sa Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins
RS61810B1 (sr) 2014-05-13 2021-06-30 Hoffmann La Roche Deuterisana heterociklična jedinjenja i njihova upotreba kao sredstva za snimanje
WO2016037106A1 (en) * 2014-09-05 2016-03-10 Allosteros Therapeutics, Inc CaMKII INHIBITORS AND USES THEREOF
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸
HUE048321T2 (hu) 2014-10-24 2020-07-28 Bristol Myers Squibb Co Karabazol származékok
SG10201903578VA (en) 2014-10-24 2019-05-30 Bristol Myers Squibb Co Indole carboxamides compounds useful as kinase inhibitors
EP3209652B1 (en) 2014-10-24 2020-04-15 Bristol-Myers Squibb Company Tricyclic atropisomer compounds
JP6579670B2 (ja) * 2015-02-02 2019-09-25 ユーシービー バイオファルマ エスピーアールエル ９ｈ−ピロロ−ジピリジン誘導体
CN105566269B (zh) * 2015-03-27 2018-07-10 北京大学 香豆素衍生物的制备、药理作用及治疗瘙痒的应用
CN105524034B (zh) * 2015-03-27 2018-08-17 北京大学 香豆素衍生物的制备、药理作用及治疗脑缺血的应用
US11253501B2 (en) 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
EP3118202A1 (en) 2015-07-15 2017-01-18 AC Immune S.A. Dihydropyridopyrrole derivatives as tau-pet-ligands
WO2017009454A1 (en) 2015-07-15 2017-01-19 Ac Immune S.A. Novel imaging compounds
ES2864825T3 (es) 2015-11-13 2021-10-14 Lilly Co Eli Derivados de azetidina para la obtención de imágenes Tau
EP3411083A1 (en) * 2016-02-03 2018-12-12 Janssen Pharmaceutica NV Tau pet imaging ligands
WO2018015546A1 (en) 2016-07-22 2018-01-25 Ac Immune S.A. Compounds for imaging tau protein aggregates
SG11201811311VA (en) * 2016-07-22 2019-01-30 Ac Immune Sa Compounds for imaging tau protein aggregates
WO2018024642A1 (en) 2016-08-02 2018-02-08 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives
WO2018024643A1 (en) 2016-08-02 2018-02-08 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives
SI3510031T1 (sl) 2016-09-09 2021-03-31 F. Hoffmann-La Roche Ag Postopek za pripravo 2-(6-nitropiridin-3-il)-9H-dipirido(2,3-b;3',4'-d)pirola
TW201906818A (zh) * 2017-05-31 2019-02-16 美商５１１製藥公司 新穎氘取代之正子發射斷層掃描（ｐｅｔ）顯影劑及其藥理應用
EP3743423A1 (en) 2018-01-24 2020-12-02 AC Immune SA Gamma-carboline compounds for the detection of tau aggregates
WO2019145292A1 (en) 2018-01-24 2019-08-01 Ac Immune Sa Azacarboline compounds for the detection of tau aggregates
JPWO2019168170A1 (ja) * 2018-03-02 2021-03-04 国立大学法人 長崎大学 クロモン誘導体及びアミロイド関連疾患診断用組成物
EP4058065A4 (en) 2019-11-13 2023-05-03 Aprinoia Therapeutics Limited COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND THEIR USES
WO2023034346A1 (en) * 2021-08-30 2023-03-09 Pretzel Therapeutics, Inc. Chromen-2-one modulators of polrmt
WO2023034339A1 (en) * 2021-08-30 2023-03-09 Pretzel Therapeutics, Inc. Hydroxy and alkoxy coumarins as modulators of polrmt
US11938127B2 (en) 2021-09-28 2024-03-26 Wayne State University Methods and compositions relating to steroid hormone receptor-dependent proliferative disorders
WO2023078252A1 (en) 2021-11-02 2023-05-11 Flare Therapeutics Inc. Pparg inverse agonists and uses thereof
WO2023204967A1 (en) * 2022-04-21 2023-10-26 Virginia Commonwealth University Nlrp3 inflammasome inhibitors and compositions and uses thereof

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741476A (en) * 1992-12-21 1998-04-21 Mallinckrodt Medical, Inc. Polyhydric phenol compounds
NZ274063A (en) * 1993-09-17 1997-11-24 Smithkline Beecham Corp Cytokine suppressive anti-inflammatory drug binding protein (csbp) and its use
US6417178B1 (en) 1994-07-19 2002-07-09 University Of Pittsburgh Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
BR9611047A (pt) 1995-10-17 2000-03-08 Searle & Co Processo de deteção de ciclo oxigenase-2
JPH09165378A (ja) * 1995-12-15 1997-06-24 Seitai Kinou Kenkyusho:Kk Ｎ１−［１８ｆ］フルオロベンジル複素環化合物およびそれらの製造法
ZA989365B (en) 1997-10-15 1999-04-15 Boehringer Mannheim Pharm Corp Preparation for treating alzheimer's disease
JP2001048786A (ja) 1999-08-05 2001-02-20 Yamanouchi Pharmaceut Co Ltd 三環式ヘテロアリール誘導体
US20020115717A1 (en) 2000-07-25 2002-08-22 Francine Gervais Amyloid targeting imaging agents and uses thereof
WO2002085903A2 (en) 2001-04-23 2002-10-31 The Trustees Of The University Of Pennsylvania Amyloid plaque aggregation inhibitors and diagnostic imaging agents
KR100947913B1 (ko) 2001-08-27 2010-03-17 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 스틸벤 유도체 및 이것을 아밀로이드 플라크의 결합 및영상화에 사용하는 용도
MXPA04001153A (es) 2001-08-31 2005-02-17 Neurochem Int Ltd Derivados de amidina para tratar la amiloidosis.
EP1442039A1 (en) 2001-10-31 2004-08-04 Bayer HealthCare AG Pyrimido (4,5-b) indole derivatives
WO2003103598A2 (en) * 2002-06-07 2003-12-18 University Of North Carolina At Chapel Hill Amidine derivatives for treating amyloidosis
US20070060618A1 (en) 2002-10-24 2007-03-15 Merck & Co., Inc. Alkyne derivatives as tracers for metabotropic glutamate receptor binding
WO2004043496A1 (de) 2002-11-11 2004-05-27 Austria Wirtschaftsservice Gesellschaft M.B.H. Fluor-18-markierte fluorchinolone
GB0229686D0 (en) 2002-12-20 2003-01-29 Amersham Plc Solid-phase fluorination of benzothiazoles
WO2004058764A1 (en) 2002-12-27 2004-07-15 Bayer Healthcare Ag 4-phenyl-pyrimido [4,5-b] indole derivatives
WO2004113277A2 (en) 2003-06-23 2004-12-29 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
CA2500358A1 (en) 2003-08-13 2005-02-24 Bf Research Institute, Inc. Probes for diseases in which amyloid accumulates, agents for staining amyloid, drugs for treatment and prophylaxis of diseases with accumulated amyloid, and probes for diagnosis of neurofibrillary tangles and agents for staining neurofibrillary tangles
JP2006100537A (ja) 2004-09-29 2006-04-13 Konica Minolta Holdings Inc 有機エレクトロルミネッセンス素子、照明装置及び表示装置
US20060110787A1 (en) 2004-11-19 2006-05-25 The Board Trustees Of The University Of Arkansas Use of fluorine-18-labeled fluoroquinolone antibiotics for diagnosing and monitoring bacterial infection
JP4000353B2 (ja) * 2004-11-26 2007-10-31 国立大学法人 長崎大学 アミロイド関連疾患診断用組成物
JP2007084526A (ja) * 2004-11-26 2007-04-05 Nagasaki Univ アミロイド関連疾患診断用組成物
SI2213652T1 (sl) * 2004-12-17 2015-03-31 The Trustees Of The University Of Pennsylvania Derivati stilbena in njihova uporaba za vezavo in prikaz amiloidnih plakov
FR2885905A1 (fr) 2005-05-23 2006-11-24 Trophos Sa Nouveaux composes chimiques et leurs utilisations comme medicament
WO2007002540A2 (en) * 2005-06-24 2007-01-04 Kung Hank F Radiolabeled-pegylation of ligands for use as imaging agents
CA2616397A1 (en) 2005-08-03 2007-02-08 Centre For Addiction And Mental Health Diagnosis and treatment of mood disorders
GB0523506D0 (en) * 2005-11-18 2005-12-28 Hammersmith Imanet Ltd Novel in vivo imaging compounds
CA2630562C (en) * 2005-11-22 2013-12-31 Merck & Co., Inc. Tricyclic compounds useful as inhibitors of kinases
US8022075B2 (en) 2005-11-30 2011-09-20 Fujifilm Ri Pharma Co., Ltd. Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
AR059356A1 (es) 2006-02-14 2008-03-26 Astrazeneca Ab Nuevos radioligandos
JP2007223952A (ja) 2006-02-23 2007-09-06 Tohoku Univ アミロイドβ蛋白が蓄積する疾患の画像診断プローブ
WO2008118122A2 (en) 2006-05-08 2008-10-02 Molecular Neuroimaging, Llc Compounds and amyloid probes thereof for therapeutic and imaging uses
US7678819B2 (en) 2006-12-07 2010-03-16 The Trustees Of The University Of Pennsylvania Acetylene derivatives and their use for binding and imaging amyloid plaques
ES2415863T3 (es) 2006-12-22 2013-07-29 Incyte Corporation Heterociclos sustituidos como inhibidores de Janus Quinasas
EP1944281A1 (en) 2007-01-09 2008-07-16 Technische Universität München 18F-labeled compounds, method for the preparation and use thereof
BRPI0702640A (pt) 2007-01-10 2008-08-26 Comissao Nac Energia Nuclear processo de radiomarcação de flavonóides e sua aplicação em diagnóstico in vivo de disfunções cerebrais relacionadas aos sìtios receptores benzodiazepìnicos
JP2010524857A (ja) 2007-04-10 2010-07-22 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア フェン−ナフタレン及びフェン−キノリン誘導体、及びアミロイドプラークに結合させ、そして造影するための使用
EP2144507A4 (en) 2007-04-19 2010-05-26 Univ Pennsylvania DIPHENYL-HETEROARYL DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLATES
WO2008132454A1 (en) 2007-04-26 2008-11-06 Ge Healthcare Limited Carbolines and their use as imaging agents
US8942164B2 (en) 2007-10-22 2015-01-27 Texas Instruments Incorporated Differential CQI for OFDMA systems
JP5322180B2 (ja) 2007-07-04 2013-10-23 国立大学法人東北大学 フッ素およびヒドロキシ基で置換されたアルコキシ基を有するｐｅｔプローブ
WO2009045535A2 (en) 2007-10-04 2009-04-09 Sloan-Kettering Institute For Cancer Research Fluorine-18 derivative of dasatinib and uses thereof
PL2247558T3 (pl) 2008-02-14 2022-05-02 Eli Lilly And Company Nowe środki obrazujące do wykrywania czynnościowych zaburzeń neurologicznych
KR20110046503A (ko) 2008-07-24 2011-05-04 지멘스 메디컬 솔루션즈 유에스에이, 인크. Ａｄ 병인을 확인하기에 유용한 영상화제
JP2012051804A (ja) 2008-12-26 2012-03-15 Kyoto Univ Ｅｇ５阻害剤
EP2218464A1 (en) 2009-02-11 2010-08-18 Technische Universität München Compounds for non-invasive measurement of aggregates of amyloid peptides
PE20160159A1 (es) 2013-10-08 2016-03-18 Hoffmann La Roche Derivados de diazacarbazol como ligandos de tau para pet
JP6579670B2 (ja) 2015-02-02 2019-09-25 ユーシービー バイオファルマ エスピーアールエル ９ｈ−ピロロ−ジピリジン誘導体

Also Published As

Publication number Publication date
LT2247558T (lt) 2022-04-11
ES2907992T3 (es) 2022-04-27
EP2599763A1 (en) 2013-06-05
PL2247558T3 (pl) 2022-05-02
KR20100135235A (ko) 2010-12-24
US20110046378A1 (en) 2011-02-24
JP2011512354A (ja) 2011-04-21
CA2715390A1 (en) 2009-08-20
EP2247558B1 (en) 2022-02-02
HRP20220401T3 (hr) 2022-05-27
US8318132B2 (en) 2012-11-27
DK2247558T3 (da) 2022-02-21
PT2247558T (pt) 2022-03-21
EP2247558A1 (en) 2010-11-10
WO2009102498A1 (en) 2009-08-20
US20110091382A1 (en) 2011-04-21
HUE058352T2 (hu) 2022-07-28

Similar Documents

Publication Publication Date Title
SI2247558T1 (sl) Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij
HK1183021A1 (zh) 用於檢測神經障礙的成像劑
GB2458223B (en) Imaging device
SG2014009146A (en) Charge-balanced imaging agents
PT2345175E (pt) Configuração de sinal de referência para lte avançado
EP2296368A4 (en) IMAGING DEVICE
IL212550A0 (en) Apj receptor compounds
GB0610395D0 (en) Novel imaging agents
EP2317923A4 (en) IMAGING WITH EXTENDED RANGE
IL212551A0 (en) Cxcr4 receptor compounds
GB0712682D0 (en) Phantom for imaging apparatuses
GB2448479B (en) Improved shim for imaging magnets
EP2336821A4 (en) IMAGING DEVICE
EP2288139A4 (en) IMAGING DEVICE
GB0808878D0 (en) Seismic imaging
HK1141243A1 (en) Imaging probes
EP2352277A4 (en) IMAGING DEVICE
GB0818738D0 (en) Imaging neuroflammation
TWI372310B (en) Imaging device
GB0818151D0 (en) Imaging techniques
HK1200823A1 (en) N-alkoxyamide conjugates as imaging agents n-
EP2312828A4 (en) IMAGING DEVICE
EP2271372A4 (en) IMAGING AGENT
GB0722650D0 (en) Novel imaging method
GB0821433D0 (en) Imaging Agents